These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 20375790)
1. LyGDI is a promising biomarker for ovarian cancer. Zhen H; Yang S; Wu H; Wang S; Lv J; Ma L; Zhang X Int J Gynecol Cancer; 2010 Apr; 20(3):316-22. PubMed ID: 20375790 [TBL] [Abstract][Full Text] [Related]
2. Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian Cancer. Simmons AR; Fourkala EO; Gentry-Maharaj A; Ryan A; Sutton MN; Baggerly K; Zheng H; Lu KH; Jacobs I; Skates S; Menon U; Bast RC Cancer Prev Res (Phila); 2019 Jun; 12(6):391-400. PubMed ID: 30967390 [TBL] [Abstract][Full Text] [Related]
3. Detection of phosphatidylserine-positive exosomes as a diagnostic marker for ovarian malignancies: a proof of concept study. Lea J; Sharma R; Yang F; Zhu H; Ward ES; Schroit AJ Oncotarget; 2017 Feb; 8(9):14395-14407. PubMed ID: 28122335 [TBL] [Abstract][Full Text] [Related]
4. High expression of insulin-like growth factor binding protein-2 messenger RNA in epithelial ovarian cancers produces elevated preoperative serum levels. Lancaster JM; Sayer RA; Blanchette C; Calingaert B; Konidari I; Gray J; Schildkraut J; Schomberg DW; Marks JR; Berchuck A Int J Gynecol Cancer; 2006; 16(4):1529-35. PubMed ID: 16884361 [TBL] [Abstract][Full Text] [Related]
5. Elevated serum 8-OHdG is associated with poor prognosis in epithelial ovarian cancer. Pylväs M; Puistola U; Laatio L; Kauppila S; Karihtala P Anticancer Res; 2011 Apr; 31(4):1411-5. PubMed ID: 21508394 [TBL] [Abstract][Full Text] [Related]
6. The risk of malignancy index (RMI) in diagnosis of ovarian malignancy. Moolthiya W; Yuenyao P Asian Pac J Cancer Prev; 2009; 10(5):865-8. PubMed ID: 20162854 [TBL] [Abstract][Full Text] [Related]
7. Correlation of preoperative ROMA scores with clinical stage in epithelial ovarian cancer patients. Li QL; Wang CJ; Qi P; Zhang YX Clin Transl Oncol; 2017 Oct; 19(10):1260-1267. PubMed ID: 28444641 [TBL] [Abstract][Full Text] [Related]
8. HE4 and mesothelin: novel biomarkers of ovarian carcinoma in patients with pelvic masses. Abdel-Azeez HA; Labib HA; Sharaf SM; Refai AN Asian Pac J Cancer Prev; 2010; 11(1):111-6. PubMed ID: 20593939 [TBL] [Abstract][Full Text] [Related]
9. Activated leukocyte cell adhesion molecule soluble form: a potential biomarker of epithelial ovarian cancer is increased in type II tumors. Carbotti G; Orengo AM; Mezzanzanica D; Bagnoli M; Brizzolara A; Emionite L; Puppo A; Centurioni MG; Bruzzone M; Marroni P; Rossello A; Canevari S; Ferrini S; Fabbi M Int J Cancer; 2013 Jun; 132(11):2597-605. PubMed ID: 23169448 [TBL] [Abstract][Full Text] [Related]
10. [Diagnostic value of combining detection of human epididymis protein 4 and CA125 in patients with malignant ovarian carcinoma]. Wang MJ; Qi J; Wang H; Li XX; Wei BJ; Fu C; Gao J; Han BB Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):540-3. PubMed ID: 22093635 [TBL] [Abstract][Full Text] [Related]
11. Serum HE4 superior to CA125 in predicting poorer surgical outcome of epithelial ovarian cancer. Shen Y; Li L Tumour Biol; 2016 Nov; 37(11):14765-14772. PubMed ID: 27629144 [TBL] [Abstract][Full Text] [Related]
12. Sperm-associated antigen 9 is a promising marker for early diagnosis of endometrial cancer. Baser E; Togrul C; Ozgu E; Ayhan S; Caglar M; Erkaya S; Gungor T Asian Pac J Cancer Prev; 2013; 14(12):7635-8. PubMed ID: 24460345 [TBL] [Abstract][Full Text] [Related]
13. Prognostic and predictive relevance of CA-125 at primary surgery of ovarian cancer. Mury D; Woelber L; Jung S; Eulenburg C; Choschzick M; Witzel I; Schwarz J; Jaenicke F; Mahner S J Cancer Res Clin Oncol; 2011 Jul; 137(7):1131-7. PubMed ID: 21344262 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic Performance of Serum Human Epididymis Protein 4 (HE4) for Prediction of Malignancy in Ovarian Masses. Dewan R; Dewan A; Jindal M; Bhardawaj M Asian Pac J Cancer Prev; 2019 Apr; 20(4):1103-1108. PubMed ID: 31030480 [TBL] [Abstract][Full Text] [Related]
15. Oviductal glycoprotein (OVGP1, MUC9): a differentiation-based mucin present in serum of women with ovarian cancer. Maines-Bandiera S; Woo MM; Borugian M; Molday LL; Hii T; Gilks B; Leung PC; Molday RS; Auersperg N Int J Gynecol Cancer; 2010 Jan; 20(1):16-22. PubMed ID: 20130498 [TBL] [Abstract][Full Text] [Related]
16. Validation and characterization of human kallikrein 11 as a serum marker for diagnosis of ovarian carcinoma. McIntosh MW; Liu Y; Drescher C; Urban N; Diamandis EP Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4422-8. PubMed ID: 17671125 [TBL] [Abstract][Full Text] [Related]
17. Clinical utility of circulating matrix metalloproteinase-7 (MMP-7), CC chemokine ligand 18 (CCL18) and CC chemokine ligand 11 (CCL11) as markers for diagnosis of epithelial ovarian cancer. Zohny SF; Fayed ST Med Oncol; 2010 Dec; 27(4):1246-53. PubMed ID: 19937162 [TBL] [Abstract][Full Text] [Related]
18. Clinical usefulness of high levels of C-reactive protein for diagnosing epithelial ovarian cancer. Yang D; Li H; Sun X; Yang S; Wang K; Liu Z Sci Rep; 2020 Nov; 10(1):20056. PubMed ID: 33208875 [TBL] [Abstract][Full Text] [Related]
19. Does HE4 have a role as biomarker in the recurrence of ovarian cancer? Plotti F; Capriglione S; Terranova C; Montera R; Aloisi A; Damiani P; Muzii L; Scaletta G; Benedetti-Panici P; Angioli R Tumour Biol; 2012 Dec; 33(6):2117-23. PubMed ID: 22875782 [TBL] [Abstract][Full Text] [Related]
20. Impact of Preoperative Serum Levels of CA 125 on Epithelial Ovarian Cancer Survival. Pradjatmo H; Pradjatmo H Asian Pac J Cancer Prev; 2016; 17(4):1881-6. PubMed ID: 27221870 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]